Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Additional contribution to the liquidity contract



Additional contribution

to NATUREX’s liquidity contract with NATIXIS


 


Press release

Avignon, February 22nd, 2012


 


 


Pursuant to the liquidity contract granted to NATIXIS, NATUREX made an additional contribution for an amount of 300,000 euros on February 16th, 2012.


 


During the half-year report as of December 31st, 2011, the following elements were in the liquidity account:



  • 4,660 NATUREX shares

  • 145,664.01 euros

For information, the following elements appeared on the liquidity account at the time of the implementation of the liquidity contract on June 18th, 2009:



  • 923 NATUREX shares

  • 277,801.85 euros

 


 


Download our press releases and other publications on www.naturex.com


 


Naturex has been listed since October 1996 on NYSE Euronext Paris, Compartment B (MidCaps)






NATUREX Number of shares comprising the capital:7,705,580

  • 6,318,272 ordinary shares (ISIN FR0000054694)

  • 1,387,308 preferred shares (ISIN FR0010833251)

Naturex is a component of the CAC Small and Gaïa indexes.

Naturex is eligible for "long only" Deferred Settlement Service (SRD).

Naturex has implemented a Sponsored Level I American Depositary Receipt (ADR) program, which trades on over-the-counter market in the United States under symbol NTUXY.



TICKER: NRX - Reuters : NATU.PA - Bloomberg : NRX:FP - DR Symbol: NTUXY

 


About Naturex


NATUREX is a global leader in specialty plant-based natural ingredients.

The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


NATUREX’s head office is based in Avignon, France. The company employs more than 1,000 people with high-performance manufacturing operations across 14 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland), as well as in Morocco, the United States, Brazil and Australia. It also has a global presence through a dedicated network of sales offices in 19 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil and Mexico).


NATUREX's development is supported by positive underlying trends linked to a fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.


 



  • Contacts





Jacques Dikansky

President and Chief Executive Officer

Tel.: +33 (0)4 90 23 96 89

[email protected]





Carole Alexandre

Investor Relations

Tel.: +33 (0)4 90 23 78 28

[email protected]
Thierry Lambert

Vice-President and Chief Financial Officer

Tel.: +33 (0)4 90 23 96 89

[email protected]





Anne Catherine Bonjour

Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

[email protected]

Information réglementée
Rachat d'actions / contrat de liquidité :

- Information relative au contrat de liquidité

Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-26839-cp-naturex-220212.pdf

<!-- 90 -->

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews

Like: 0
Teilen

Kommentare